Report cover image

Best Selling Pharmaceutical Drugs in 2021

Publisher BCC Research
Published Feb 28, 2023
Length 255 Pages
SKU # WA17783388

Description

Best Selling Pharmaceutical Drugs in 2021

Report Scope:

This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies, and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe, and Japan.

Report Includes:

An overview of the best-selling pharmaceutical drugs in 2021

Revenue forecast of the top 50 pharmaceutical drugs and assessment of their regulatory landscape

Description of the pharmaceutical drugs applications and information on pharmaceutical drugs patents

Detailed company profiles of the top 50 pharmaceutical drugs

Companies Mentioned

A. MENARINI Industrie Farmaceutiche Riunite S.r.l.
ABBOTT
ABBVIE INC.
ALEXION PHARMACEUTICALS INC.
AMGEN INC.
ASAHI KASEI CORP.
ASTELLAS PHARMA INC.
ASTRAZENECA
AUROBINDO PHARMA
Bausch Health Companies Inc.
BAYER AG
BIOGEN
Boehringer Ingelheim International GmbH
BRISTOL-MYERS SQUIBB CO.
CHINA NATIONAL PHARMACEUTICAL GROUP CORP. (SINOPHARM)
CHUGAI PHARMACEUTICAL CO. LTD.
CSL LTD.
DAIICHI SANKYO CO. LTD.
DR. REDDY’S LABORATORIES LTD.
EISAI CO. LTD.
ELI LILLY AND CO.
ENDO INTERNATIONAL PLC
F. HOFFMANN-LA ROCHE LTD. (ROCHE)
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
GRIFOLS S.A.
H. LUNDBECK A/S
INCYTE
IPSEN PHARMA
JOHNSON & JOHNSON SERVICES INC.
MALLINCKRODT PLC
MERCK & CO. INC.
MERCK KGAA
Moderna Inc.
NOVARTIS AG
NOVO NORDISK A/S
OTSUKA HOLDINGS CO. LTD.
PFIZER INC.
REGENERON PHARMACEUTICALS INC.
SANOFI
SERVIER LABORATORIES
SHANGHAI PHARMACEUTICALS HOLDING
Shionogi & Co. Ltd.
STADA ARZNEIMITTEL AG
Sumitomo Pharma Co. Ltd
SUN PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
UCB S.A.
VERTEX PHARMACEUTICALS INC.
VIATRIS INC.
ZYDUS CADILA"

Table of Contents

255 Pages
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 Methodology
1.4.1 Primary Data and Information Gathering
1.4.2 Secondary Data and Information Gathering
1.4.3 Market Revenue Forecasts
1.5 Analyst's Credentials
1.6 BCC Custom Research
1.7 Related BCC Research Reports
Chapter 2 Global Pharmaceutical Drug Market
2.1 Overview
2.2 Key Strategies of Major Pharmaceutical Drugs Manufacturers
2.2.1 Distribution Network
2.2.2 Trends
2.2.3 Mergers and Acquisitions
2.2.4 Recommendations
2.3 Key Developments of the Major Pharmaceutical Drugs Manufacturers
2.3.1 Mergers and Acquisitions
2.3.2 Agreements, Joint Ventures, Expansions, Divestments, and Investments
2.3.3 New Product Launches and Approvals
2.4 Long-Term Outlook
Chapter 3 Regulatory Structure: Pharmaceutical Drug Market
3.1 Regulatory Background
3.2 Regulatory Systems for Biopharmaceuticals by Region
3.2.1 U.S.
3.2.2 Europe
3.2.3 Japan
3.3 Regulatory Systems for Pharmaceuticals by Region
3.3.1 U.S.
3.3.2 Japan
3.3.3 India
3.3.4 Brazil
3.4 Regulations for Vaccines
3.4.1 Current Regulatory Issues for Vaccines
3.4.2 Moderna Vaccine Regulation in the U.K.
3.5 Key Regulatory Updates 2021
3.5.1 Pharmaceuticals
3.5.2 Medical Devices
3.6 Code of Federal Regulations (CFR)
3.7 Good Manufacturing Practice (GMP) Compliance
3.8 Establishment Registration
3.9 Drug Registration and Listing
3.10 Local Agent Requirements
3.10.1 Responsibilities of the U.S. agent
Chapter 4 Pricing and Reimbursement: Pharmaceuticals and Biologics
4.1 Pricing and Reimbursement Background
4.2 Pricing and Reimbursement of Pharmaceuticals and Biologics by Region
4.2.1 U.S.
4.2.2 Europe
4.2.3 Japan
4.3 Pricing and Reimbursement Challenges for Pharmaceuticals
4.3.1 Patented Medicines Price
4.3.2 Prices of Older Drugs
Chapter 5 Company Profiles
ABBOTT
ABBVIE INC.
ALEXION PHARMACEUTICALS INC.
AMGEN INC.
ASTELLAS PHARMA INC.
ASTRAZENECA
ASAHI KASEI CORP.
AUROBINDO PHARMA
BAUSCH HEALTH COMPANIES INC.
BAYER AG
BIOGEN
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB CO.
CHUGAI PHARMACEUTICAL CO. LTD.
CSL LTD.
DAIICHI SANKYO CO. LTD.
DR. REDDY'S LABORATORIES LTD.
EISAI CO. LTD.
ELI LILLY AND CO.
ENDO INTERNATIONAL PLC
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
GRIFOLS S.A.
H. LUNDBECK A/S
INCYTE
IPSEN PHARMA
JOHNSON & JOHNSON SERVICES INC.
MALLINCKRODT PLC
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.
MERCK & CO. INC.
MERCK KGAA
MODERNA INC.
NOVARTIS AG
NOVO NORDISK A/S
OTSUKA HOLDINGS CO. LTD.
PFIZER INC.
REGENERON PHARMACEUTICALS INC.
F. HOFFMANN-LA ROCHE LTD. (ROCHE)
SANOFI
SERVIER LABORATORIES
SHANGHAI PHARMACEUTICALS HOLDING
SHIONOGI & CO. LTD.
CHINA NATIONAL PHARMACEUTICAL GROUP CORP. (SINOPHARM)
STADA ARZNEIMITTEL AG
SUMITOMO PHARMA CO. LTD
SUN PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
UCB S.A.
VERTEX PHARMACEUTICALS INC.
VIATRIS INC.
ZYDUS CADILA

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us